Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial is evaluating the safety and effectiveness of oral roflumilast for adults with moderate-to-severe psoriasis; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roflumilast (roflumilast)

Snippet

Sponsor: Ahmed Ibrahim | Conditions: Psoriasis (PsO) | Phase 2 | Status: RECRUITING